CD8A and breast carcinoma: Another recent study showed that a nuclear receptor, NR1D1, enhances the antitumor CD8 + T cell response to breast cancer by promoting DNA damage-induced accumulation of cytosolic DNA fragments, which leads to activation of cGAS-STING signaling and downstream type I IFN signaling [40].